|
Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)
|
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
|
Mar. 31, 2015
Segment
|
Dec. 31, 2014
Segment
|
Dec. 31, 2013
|
|
| Summary Of Significant Accounting Policies [Line Items] | |||
| Restricted cash | $ 0us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue | $ 72,497us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue | |
| Trade accounts receivable | 0us-gaap_AccountsReceivableNetCurrent | 481,810us-gaap_AccountsReceivableNetCurrent | |
| Allowance for doubtful accounts | 0us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent | 0us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent | |
| Impairments loss | 0us-gaap_ImpairmentOfLongLivedAssetsHeldForUse | 0us-gaap_ImpairmentOfLongLivedAssetsHeldForUse | |
| Milestones arrangement, categories description | Pieris Pharmaceuticals, Inc. aggregates milestones into three categories (i) research milestones, (ii) development milestones and (iii) commercial milestones. | The Company aggregates milestones into three categories (i) research milestones, (ii) development milestones and (iii) commercial milestones. | |
| Number of Operating segment | 1us-gaap_NumberOfOperatingSegments | 1us-gaap_NumberOfOperatingSegments | |
| Stock equivalents granted | 0us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment | ||
| Effective tax rate | 0.00%us-gaap_EffectiveIncomeTaxRateContinuingOperations | ||
| Fair Value, Inputs, Level 1 [Member] | |||
| Summary Of Significant Accounting Policies [Line Items] | |||
| Cash and Cash Equivalents, Fair Value |
$ 471,011us-gaap_CashAndCashEquivalentsFairValueDisclosure / us-gaap_FairValueByFairValueHierarchyLevelAxis = us-gaap_FairValueInputsLevel1Member |
$ 4,800,573us-gaap_CashAndCashEquivalentsFairValueDisclosure / us-gaap_FairValueByFairValueHierarchyLevelAxis = us-gaap_FairValueInputsLevel1Member |
$ 3,307,520us-gaap_CashAndCashEquivalentsFairValueDisclosure / us-gaap_FairValueByFairValueHierarchyLevelAxis = us-gaap_FairValueInputsLevel1Member |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. No definition available.
|
| X | ||||||||||
|
- Definition
The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. For a classified balance sheet represents the current portion only (the noncurrent portion has a separate concept); there is a separate and distinct element for unclassified presentations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
A description of each milestone and related contingent consideration as well as a description of whether or not each milestone(s) is considered substantive. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|